Status:
COMPLETED
The Effect of Acupuncture on the Treatment of Endovenous Ablation on Pain, IL17 and IL 23
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Pain
Interleukin
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Acupuncture has emerged in China about 2,000 years ago and is one of the oldest medical procedures in the world. Acupuncture continued to evolve and develop over the centuries, and gradually became on...
Detailed Description
Patients will be divided into two groups. Control group (Group C, n: 35) and Acupuncture group (Group A, n: 35). Inclusion criteria: willing to participate in the study, being in the 18-65 age range, ...
Eligibility Criteria
Inclusion
- Volunteers to participate in the study,
- 18-65 years of age,
- patients with a saphenous vein diameter greater than 5.5 mm
- small saphenous vein diameter of less than 4 mm with reflux for greater than 0.5 s
Exclusion
- Patients outside the 18-65 age range,
- patients with deep venous system obstruction,
- patients who have previously used another invasive treatment method (thermal and chemical ablation, surgery),
- patients with heart and kidney failure,
- patients with secondary varicose veins,
- patients with hypercoagulable state patients,
- patients with local or systemic infections,
- patients with obesity (body mass index\> 35),
- patients with impaired consciousness,
- patients who do not want to participate in the study.
Key Trial Info
Start Date :
January 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03828877
Start Date
January 29 2019
End Date
March 7 2019
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kahramanmaras Sutcu Imam University Faculty of Medicine
Kahramanmaraş, Onikişubat, Turkey (Türkiye), 251/A 46040